KEVIN K.W. WANG, PH.D.
Chief Scientific Officer, Founder, Banyan Biomarkers
Director of the Center for Neuroprotemics and Biomarkers Research
Scientific Director of the Center for Traumatic Brain Injury Studies
Associate Professor of Psychiatry and Neuroscience
McKnight Brain Institute of the University of Florida

Dr. Wang obtained his Ph.D. in Pharmaceutical Sciences with Distinction from the University of British Columbia in Vancouver in 1989. Dr. Wang is internationally recognized for his original contributions to the field of CNS disorders-linked proteolytic enzymes. He joined Parke-Davis Pharmaceutical Research (Ann Arbor, MI) in 1991, and following the company's merger with Pfizer Inc.(2000), he became Group Leader of CNS Therapeutics and chaired the multidisciplinary CNS New targets team. He also co-chaired the Far East Scientific Opportunity Team involved in exploring values of traditional herbal medicine. He published more than 100 peer-reviewed papers, reviews and book chapters and co-authored eight US patents. He co-edited a book entitled "Calpain: the Pharmacology and Toxicology of a Calcium-dependent Protease" in 2000. He is on the Editorial Board of the journal Cell & Molecular Biology Letter and Journal of Neurotrauma. In 2002, he became Associate Professor of Psychiatry and Neuroscience at the McKnight Brian Institute of the University of Florida (Gainesville, FL). He also serves as Associate Director of the Center for Traumatic Brain Injury Studies and Director of the Center of Neuroproteomics and Biomarkers Research. In 2002, he co-founded Banyan biomarkers Inc. (Alachua, Florida), where he is also the Chief Scientific Officer.